6 Analysts Have This to Say About Cerence
Cerence (NASDAQ:CRNC) has observed the following analyst ratings within the last quarter:
Needham Maintains Buy on Cerence, Lowers Price Target to $30
Needham analyst Rajvindra Gill maintains Cerence (NASDAQ:CRNC) with a Buy and lowers the price target from $46 to $30.
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Wells Fargo Maintains Overweight on Cerence, Lowers Price Target to $64
Wells Fargo analyst Colin Langan maintains Cerence (NASDAQ:CRNC) with a Overweight and lowers the price target from $66 to $64.
Expert Ratings for Cerence
Cerence (NASDAQ:CRNC) has observed the following analyst ratings within the last quarter:
